Available from Alvogen
Teriparatide Injection
Replace and reinforce bone density
Consult your healthcare provider to determine if it's right for you.
The first FDA-approved teriparatide alternative for Forteo®*
What is Teriparatide Injection?
Teriparatide Injection is a medication designed to assist in building new bone, and is comprised of protein similar to one naturally produced by the body. It has also been shown to help increase bone strength.†
Teriparatide Injection helps to grow healthy bones by increasing bone mineral density and bone strength, which may prevent fractures.
Proven Results
Postmenopausal women with osteoporosis, who were at high risk for fracture, experienced significantly increased bone mineral density in the spine, after taking Teriparatide Injection with calcium and vitamin D. These results were demonstrated at 3 months, and throughout the treatment period.
The risk of new spine fractures was reduced by approximately two thirds. The risk of new fractures in other bones—including the ankle/foot, hip, upper arm, pelvis, ribs, and wrist—was cut in half.‡
* Forteo is a registered trademark of Eli Lilly and Company, which has no affiliation with Alvogen.
† Only proven in postmenopausal women with osteoporosis.
‡ This clinical study involved 1,637 postmenopausal women with osteoporosis, of whom 90% had a spine fracture. 541 women took a daily 20-mcg dose of Teriparatide Injection; 544 took a placebo for a median time of 19 months, and a maximum of 2 years. All women took calcium and vitamin D daily.
Build new bone with Alvogen’s Teriparatide Injection
Indications & Important Safety Information
Indications
Teriparatide Injection is a prescription medicine used in both men and postmenopausal women with osteoporosis who are at high risk for having bone fractures—defined as those who have had a fracture related to osteoporosis, who are at high risk for fracture, or who cannot use other osteoporosis treatments. It is also used for treating osteoporosis associated with glucocorticoid medicines, such as prednisone, in patients who are at high risk for fracture.
Important Safety Information
Do not use Teriparatide Injection if you are allergic to any of its ingredients. Serious allergic reactions may occur.
Before taking Teriparatide Injection, inform your healthcare provider if you have a bone disease other than osteoporosis; have bone cancer or a history of bone cancer, have trouble injecting yourself, are a child or young adult whose bones are still growing, have had radiation therapy, have a greater risk of getting bone cancer, have been diagnosed with too much calcium in your blood, have or have had a skin condition with wounds caused by too much calcium, have or have had kidney stones, take medicines that contain digoxin, are pregnant or thinking about becoming pregnant, are breastfeeding or plan to breastfeed, or have any other medical conditions. Tell your healthcare provider about all the medicines you take.
Teriparatide can cause serious side effects, including bone cancer, increased calcium in your blood, worsening of your kidney stones, and a decrease in blood pressure upon changing positions. Dizziness, accelerated heartbeat, or a feeling of faintness may occur, usually within four hours of taking Teriparatide Injection, and typically go away within a few hours. You should not use Teriparatide Injection for more than two years during your lifetime unless your healthcare provider finds that you need longer treatment.
Other side effects include pain, nausea, and joint aches.
Injection site reactions can include pain, swelling and bruising.
If symptoms persist, stop taking Teriparatide Injection and call your healthcare provider.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088 to report any additional negative side effects to the FDA.
For additional safety information, please see the Medication Guide and Prescribing Information, including the full User Manual which accompanies the delivery device.
